K. S. Ross

Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages.

K. S. Ross, H. Guess, H. Carter, 2005, Urology.

Incidence and risk reduction of long-term outcomes: a comparison of benign prostatic hyperplasia with several other disease areas.

C. Roehrborn, K. S. Ross, C. Girman, 2000, Urology.

RATIONAL PSA SCREENING STRATEGIES FOR PROSTATE CANCER: COMPUTER SIMULATIONS OF AGE RANGES, PSA CUTOFFS, AND TESTING INTERVALS

J. Epstein, K. S. Ross, H. Guess, 1999 .

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

H A Guess, K. S. Ross, H. Guess, 2000, JAMA.